Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Wild-type p53 inhibits replication-associated homologous recombination

Abstract

In mammalian cells homologous recombination is stimulated, when the replication fork stalls at DNA breaks or unrepaired lesions. The tumor suppressor p53 downregulates homologous recombination independently of its transcriptional transactivation function and has been linked to enzymes of DNA recombination and replication. To study recombination with respect to replication, we utilized a SV40 virus based assay, to follow the synchronous events after primate cell infection. γ-ray treatment at different times after viral entry unveiled an increase of interchromosomal exchange frequencies, when the damage was introduced during DNA synthesis. Elevated recombination frequencies were fully suppressed by p53. With respect to the downregulation of spontaneous recombination, we noticed a requirement for active p53 molecules, when replication started. After a transient treatment with replication inhibitors, we observed inhibition of the drug induced recombination by p53, particularly for the elongation inhibitor aphidicolin. Consequently, we propose that p53 is a surveillance factor of homologous recombination at replication forks, when they stall as a consequence of endogenous or of exogenously introduced damage.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Akyüz N, Boehden GS, Sösse S, Rimek A, Preuss U, Scheidtmann KH, Wiesmüller L . 2002 Mol. Cell. Biol., in press

  • Bertrand P, Rouillard D, Boulet A, Levalois C, Soussi T, Lopez BS . 1997 Oncogene 14: 1117–1122

  • Braithwaite AW, Stürzbecher HW, Addison C, Palmer C, Rudge K, Jenkins JR . 1987 Nature 329: 458–460

  • Brush GS, Kelly TJ, Stillman B . 1995 Methods Enzymol. 262: 522–548

  • Cox MM, Goodman MF, Kreuzer KN, Sherratt DJ, Sandler SJ, Marians KJ . 2000 Nature 404: 37–41

  • Dai Y, Gold B, Vishwanatha JK, Rhode SL . 1994 Virology 205: 210–216

  • Dudenhöffer C, Rohaly G, Will K, Deppert W, Wiesmüller L . 1998 Mol. Cell. Biol. 18: 5332–5342

  • Dudenhöffer C, Kurth M, Janus F, Deppert W, Wiesmüller L . 1999 Oncogene 18: 5773–5784

  • Fernandez JL, Vazquez-Gundin F, Rivero MT, Genesca A, Gosalvez J, Goyanes V . 2001 Exp. Cell Res. 270: 102–109

  • Gersten KM, Kemp CJ . 1997 Nature Genet. 17: 378–379

  • Gilbert DM, Neilson A, Miyazawa H, DePamphilis ML, Burhans WC . 1995 J. Biol. Chem. 270: 9597–9606

  • Gottifredi V, Shieh S-Y, Taya Y, Prives C . 2001 Proc. Natl. Acad. Sci. USA 98: 1036–1041

  • Haber J . 1999 Trends Biol. Sci. 24: 271–275

  • Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC . 1994 Nucleic Acids Res. 22: 3551–3555

  • Huang P . 1998 Oncogene 17: 261–270

  • Ishizaki K, Ejima Y, Matsunaga T, Hara R, Sakamoto A, Ikenaga M, Ikawa Y, Aizawa S . 1994 Int. J. Cancer 58: 254–257

  • Janz C, Süsse S, Wiesmüller L . 2002 Oncogene 21: 2130–2140

  • Jimenez GS, Nister M, Stommel JM, Beeche M, Barcarse EA, Zhang XQ, O'Gorman S, Wahl GM . 2000 Nature Genet. 26: 37–43

  • Kalejta RF, Hamlin JL . 1997 Exp. Cell Res. 231: 173–183

  • Kawasaki I, Bae YS, Eki T, Kim Y, Ikeda H . 1994 Mol. Cell. Biol. 14: 4173–4182

  • Kaufmann WK, Wilson SJ . 1994 Mutat. Res. 314: 67–76

  • Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV . 1999 Science 85: 1733–1737

  • Kühn C, Müller F, Melle C, Nasheuer HP, Janus F, Deppert W, Grosse F . 1999 Oncogene 18: 769–774

  • Larner JM, Lee H, Little RD, Dijkwel PA, Schildkraut CL, Hamlin JL . 1999 Nucleic Acids Res. 27: 803–809

  • Levenson V, Hamlin JL . 1993 Nucleic Acids Res. 21: 3997–4004

  • Levine A . 1997 Cell 88: 323–331

  • Liang F, Han M, Romanienko PJ, Jasin M . 1998 Proc. Natl. Acad. Sci. USA 95: 5172–5177

  • Lin J-Y, Simmons DT . 1991 J. Virol. 65: 2066–2072

  • Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD . 1992 Cell 70: 923–935

  • Miller SD, Farmer G, Prives G . 1995 Mol. Cell. Biol. 15: 6554–6660

  • Saintigny Y, Lopez BS . 2002 Oncogene 21: 488–492

  • Saintigny Y, Delacote F, Vares G, Petitot F, Lambert S, Averbeck D, Lopez B . 2001 EMBO J. 20: 3861–3870

  • Saintigny Y, Rouillard D, Chaput B, Soussi T, Lopez BS . 1999 Oncogene 18: 3553–3565

  • Sarasin AR, Hanawalt PC . 1978 Proc. Natl. Acad. Sci. USA 75: 346–350

  • Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM . 1997 Cell 90: 425–435

  • Stürzbecher H-W, Donzelmann B, Henning W, Knippschild U, Buchhop S . 1996 EMBO J. 15: 1992–2002

  • Süsse S, Janz C, Janus F, Deppert W, Wiesmüller L . 2000 Oncogene 19: 4500–4512

  • Thompson LH, Schild D . 2001 Mutat. Res. 477: 131–153

  • Tooze J (ed.) . 1980 DNA Tumor Viruses Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press

    Google Scholar 

  • Von der Weth A, Deppert W . 1993 J. Virol. 67: 886–893

  • Wiesmüller L, Cammenga J, Deppert WW . 1996 J. Virol. 70: 737–744

  • Willers H, McCarthy EE, Wu B, Wunsch H, Tang W, Taghian DG, Xia F, Powell SN . 2000 Oncogene 19: 632–639

  • Zhou J, Ahn J, Wilson SH, Prives C . 2001 EMBO J. 20: 914–923

Download references

Acknowledgements

We thank Evelyn Bendrat for competent experimental assistance. This work was supported by the Deutsche Forschungsgemeinschaft, grants Wi 1376/1-4 & -5.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa Wiesmüller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janz, C., Wiesmüller, L. Wild-type p53 inhibits replication-associated homologous recombination. Oncogene 21, 5929–5933 (2002). https://doi.org/10.1038/sj.onc.1205757

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205757

Keywords

This article is cited by

Search

Quick links